ImmunityBio Inc
ImmunityBio Inc [IBRX] Revenue clocked in at $82.56 million, down -59.62% YTD: What’s Next?
Edison Baldwin
ImmunityBio Inc [NASDAQ: IBRX] price plunged by -0.93 percent to reach at -$0.02. A sum of 6523156 shares traded at ...
ImmunityBio Inc [IBRX] Revenue clocked in at $56.60 million, down -60.08% YTD: What’s Next?
Misty Lee
ImmunityBio Inc [NASDAQ: IBRX] loss -7.96% on the last trading session, reaching $2.08 price per share at the time. ImmunityBio ...
ImmunityBio Inc [IBRX] Stock trading around $2.48 per share: What’s Next?
Caleb Clifford
ImmunityBio Inc [NASDAQ: IBRX] gained 5.08% or 0.12 points to close at $2.48 with a heavy trading volume of 10872792 ...
Market Analysts see ImmunityBio Inc [IBRX] gaining to $5. Time to buy?
Brandon Evans
ImmunityBio Inc [NASDAQ: IBRX] price plunged by -1.19 percent to reach at -$0.03. A sum of 9574256 shares traded at ...
why ImmunityBio Inc [IBRX] is a Good Choice for Investors After New Price Target of $10.20
Brandon Evans
ImmunityBio Inc [NASDAQ: IBRX] slipped around -0.08 points on Tuesday, while shares priced at $2.59 at the close of the ...
Piper Sandler lifts ImmunityBio Inc [IBRX] price estimate. Who else is bullish?
Edison Baldwin
ImmunityBio Inc [NASDAQ: IBRX] surged by $0.14 during the normal trading session on Monday and reaching a high of $2.75 ...
